COLORADO SPRINGS, Colo.,
Oct. 1, 2013 /PRNewswire/
-- Endocan Corporation (NASDAQ OTC: XCHC), a U.S. Company
specializing primarily in cannabinoid formulation-based health and
wellness solutions, is pleased to announce Canada market opens and The Netherlands gets the green light to import
product into Canada.
Dr. Dorothy Bray, the President
of the Endocan Corporation, stated, "It is impressive that Health
Canada had chosen to open the market to inspected and certified
medical cannabis. The Canadian government's support to
monitor and provide high quality medical cannabis will bring clear
benefits to Canadian patients. We look forward to bringing
our products and services to the market with such a significant
global awareness and new political climate."
The Canadian Press article, as released by the Huffington
Post:
OTTAWA - The Conservative
government is launching a $1.3-billion free market in medical marijuana
this Tuesday, eventually providing an expected 450,000 Canadians
with quality weed.
Health Canada is phasing out an
older system on Monday that mostly relied on small-scale, homegrown
medical marijuana of varying quality, often diverted illegally to
the black market.
In its place, large indoor marijuana farms certified by the RCMP
and health inspectors will produce, package and distribute a range
of standardized weed, all of it sold for whatever price the market
will bear. The first sales are expected in the next few weeks,
delivered directly by secure courier.
"We're fairly confident that we'll have a healthy commercial
industry in time," Sophie Galarneau,
a senior official with the department, said in an interview.
"It's a whole other ball game."
The sanctioned birth of large-scale, free-market marijuana
production comes as the Conservatives pillory Liberal Leader
Justin Trudeau's campaign to
legalize recreational marijuana.
Health Canada is placing no
limits on the number of these new capital-intensive facilities,
which will have mandatory vaults and security systems.
Private-dwelling production will be banned. Imports from places
such as the Netherlands will be
allowed.
Please click the following link to read the complete
announcement and view the accompanying video:
http://www.huffingtonpost.ca/2013/09/29/canada-medical-marijuana_n_4013334.html?ir=Canada+Business
About Endocan Corporation
Endocan Corporation is currently developing new natural cannabinoid
containing products based on innovative formulations to utilize the
unique and potent benefits of the cannabis and hemp plants.
Medicinal properties of cannabis and hemp have been known and
applied for thousands of years. With the aid of scientific
research, Endocan Corporation is translating such knowledge into
development of effective cannabinoid formulation-based health and
wellness solutions as well as cosmeceutical, nutraceutical, and
food brands throughout the world. The Company's health and
wellness, nutritional, and cosmetics lines will address personal
needs and will evolve with the introduction of new formulations and
products, advancing the Company within the expanding
multibillion-dollar global market.
Forward Looking Statements
This Press Release includes forward-looking statements within the
meaning of Section 27A of the Securities Act of 1933 and Section
21E of the Securities Act of 1934. A statement containing words
such as "anticipate," "seek," intend," "believe," "plan,"
"estimate," "expect," "project," "plan," or similar phrases may be
deemed "forward-looking statements" within the meaning of the
Private Securities Litigation Reform Act of 1995. Some or all of
the events or results anticipated by these forward-looking
statements may not occur. Factors that could cause or contribute to
such differences include the future U.S. and global economies, the
impact of competition, and the Company's reliance on existing
regulations regarding the use and development of cannabis-based
drugs. The Company does not undertake any duty nor does it intend
to update the results of these forward-looking statements.
Endocan Corporation
President
Dr. Dorothy Bray
info@xchangecorp.com
www.xchangecorp.com
+1.866.326.5595
Investment Inquiries
Robert Kane
CFO, Sr Vp of Business Development
rkane@xchangecorp.com
+1.561.420.4824
SOURCE Endocan Corporation